RxDoctor Payments Data

Joshua Alley, MD

Surgery · Lynchburg, VANPI 1982816427

Payments from drug & device makers

What this record shows

The money is spread across several categories — education (43.0%), travel and lodging and food and beverage — rather than concentrated in one kind of arrangement. Intuitive Surgical accounts for 84.4% of it on its own, with 16 other manufacturers making up the rest. Reporting peaked in 2022 at $7,253 and has fallen 95.7% since, to $315 in 2025. Among surgery clinicians in VA with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$15,960in general payments, 2019–2025

Across 93 payments — averaging $171.62 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Intuitive Surgical$13K
  • Davol Inc.$607
  • Medtronic$353
  • Medical Device Business Services, Inc.$346
  • Johnson & Johnson$259
  • Standard Bariatrics, Inc.$250
  • plus $677 from 11 others

What the payments were for

  • Consulting fees$2502%
  • Travel & lodging$5,11132%
  • Food & beverage$3,72023%
  • Education$6,86343%
  • Gifts$160%

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$15,960 in reported general payments places this provider in the 90th percentile of 675 surgery providers in Virginia.

See all surgery providers in Virginia

Medicare billing

Part B allowed, 2024
$29,913
Medicare patients
67
Services billed
114

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
OzempicSemaglutide18$20,228
Ursodiol37$7,855
Omeprazole53$677
Scopolamine21$295
Ondansetron OdtOndansetron20$142
Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen14$32

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Novo NordiskOzempic$183$20,22818 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 675 surgery providers in Virginia.

Other surgery in Lynchburg

See the full list for Virginia

Where these figures come from

Is this you, or does something look wrong? →